Not Out of the Woods yet-a Case of Recurrent Euglycemic Diabetic Ketoacidosis Secondary to Empagliflozin and Pancreatitis

Marvin Wei Jie Chua, Sengkang General Hospital

Open Access

https://doi.org/10.24966/dmd-201x/100038

Copy DOI

Journal: Diabetes & Metabolic Disorders	Publication Date: Mar 3, 2021
License type: cc-by

Abstract

Since their introduction, Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors have demonstrated a multitude of exceptional clinical benefits.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author